Zobrazeno 1 - 10
of 72
pro vyhledávání: '"R O Dillman"'
Publikováno v:
Cancer Immunology, Immunotherapy. 60:123-131
The use of whole cell tumor vaccines and various means of loading antigen onto dendritic cells have been under investigation for over a decade. Induction of apoptosis and the exposure of immune-stimulating proteins are thought to be beneficial for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9132ea69014fa03887d11d7fa7904a18
https://doi.org/10.1007/s00262-010-0925-y
https://doi.org/10.1007/s00262-010-0925-y
Autor:
R. O. Dillman
Publikováno v:
Neuro-Oncology. 3:35-41
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c37f49e03d7e97415ff2311236152b2
https://doi.org/10.1215/15228517-3-1-35
https://doi.org/10.1215/15228517-3-1-35
Publikováno v:
Journal of Biomedicine and Biotechnology
Journal of Biomedicine and Biotechnology, Vol 2011 (2011)
Journal of Biomedicine and Biotechnology, Vol 2011 (2011)
Metastatic melanoma patients who were treated with patient-specific vaccines consisting of dendritic cells loaded with autologous tumor cells had a 5-year survival of over 50%. Enzyme-linked immunospot (ELISPOT) has been used to detect antigen reacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939389aaea1eaca5f6bb9c10afba681e
http://europepmc.org/articles/PMC3085493
http://europepmc.org/articles/PMC3085493
Autor:
R. O. Dillman
Publikováno v:
Clinical and Experimental Medicine
CD20 has proven to be an excellent target for the treatment of B-cell lymphoma, first for the chimeric monoclonal antibody rituximab (Rituxan™), and more recently for the radiolabelled antibodies Y-90 ibritumomab tiuxetan (Zevalin™) and I-131 tos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc4b211ec1178896bc79087ccf356f7
https://pubmed.ncbi.nlm.nih.gov/16550338
https://pubmed.ncbi.nlm.nih.gov/16550338
Autor:
R O, Dillman
Publikováno v:
Clinical lung cancer. 2(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e028c1e929f1c5dc213332a608acc156
https://pubmed.ncbi.nlm.nih.gov/14731328
https://pubmed.ncbi.nlm.nih.gov/14731328
Autor:
L, Kunkel, A, Wong, T, Maneatis, J, Nickas, T, Brown, A, Grillo-López, M, Benyunes, B, Grobman, R O, Dillman
Publikováno v:
Seminars in oncology. 27(6 Suppl 12)
Rituximab (Rituxan; Genentech, Inc, South San Francisco, CA and IDEC Pharmaceutical Corporation, San Diego, CA), the first monoclonal antibody approved in the United States for the treatment of cancer, is indicated for the treatment of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20543825ab793806b82ae6deb2e18669
https://pubmed.ncbi.nlm.nih.gov/11226001
https://pubmed.ncbi.nlm.nih.gov/11226001
Autor:
R O, Dillman
Publikováno v:
Cancer metastasis reviews. 18(4)
With the FDA approval of Rituximab in 1998 for the treatment of lymphoma, and Trastuzumab in 1999 for the treatment of breast cancer, monoclonal antibodies were officially added to the therapeutic armamentarium against malignancy. Most of the side ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::592d2a74fbe7d645f8ed18b7ef0488aa
https://pubmed.ncbi.nlm.nih.gov/10855789
https://pubmed.ncbi.nlm.nih.gov/10855789
Autor:
R O, Dillman, S, Chico
Publikováno v:
Effective clinical practice : ECP. 3(1)
Radiologic tests may be overused in the staging of newly diagnosed breast cancer.To determine the frequency with which radiologic tests are used in women with newly diagnosed breast cancer and the yield of such tests in these patients.We used the tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a16198babea6a733d273605227bb9087
https://pubmed.ncbi.nlm.nih.gov/10788031
https://pubmed.ncbi.nlm.nih.gov/10788031
Publikováno v:
In vitro cellulardevelopmental biology. Animal. 36(3)
Cell lines are valuable resources for the study of the malignancy and potential therapy of human breast cancer. A major problem with adapting fresh breast tumor specimens to grow in vitro is contamination by fibroblasts. Previously, we have reported
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8381aa701dbb6b251942ecf60acdd6e0
https://pubmed.ncbi.nlm.nih.gov/10777059
https://pubmed.ncbi.nlm.nih.gov/10777059
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5(2)
We investigated the individual and combined effects of cis-retinoic acid (CRA) and/or IFN-alpha (IFN) and/or radiation therapy (RT) against a human glioma cell line (American Type Culture Collection; U373MG) to evaluate the possible radiosensitizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d41e3e87da5c2d77ed16085e2dd86b3
https://pubmed.ncbi.nlm.nih.gov/10037192
https://pubmed.ncbi.nlm.nih.gov/10037192